OPINION AND ORDER
Michelle Weiss has brought this putative class action seeking declaratory and injunctive relief pursuant to the Employee Retirement Security Income Act of 1974 (“ERISA”), 29 U.S.C. § 1001 et seq Weiss is a participant in an employee welfare benefit plan (the “Plan”) offered and subsidized by her employer. (Complaint at ¶ 14.) Defendant CIGNA Healthcare of New York, Inc. (“CHC”) is a health maintenance organization (“HMO”) retained by Weiss’ employer to provide health insurance coverage pursuant to the Plan. Defendant CIGNA Healthcare, Inc., is CHC’s corporate parent and is alleged to control the policies and practices of its subsidiary. (Compl. at ¶ 18.) The two defendants are referred to collectively in this Opinion as “CIGNA”.
Weiss alleges that CIGNA has breached the express and implied terms of the Plan as well as various fiduciary duties required under ERISA and seeks redress pursuant to the civil enforcement provisions set forth in ERISA § 502(a), 29 U.S.C. § 1132(a). CIGNA has moved for an order dismissing the complaint pursuant to Fed. R.Civ.P. 12(b)(6). In its consideration of defendants’ motion to dismiss, this court must assess the legal feasibility of Weiss’ complaint, not weigh the evidence which might be offered at trial.
See Odom v. Columbia University,
A. Weiss’ Fiduciary Duty Claim Regarding CIGNA’s Alleged “Gag Order” Policy
Defendants’ motion to dismiss is GRANTED in PART and DENIED in PART with regard to Weiss’ claim that CIGNA limits the extent to which its participating physicians may discuss medical treatments with Plan members. Weiss alleges that CIGNA engages in “an undisclosed policy” of preventing its physicians from “advising patients of treatment options which [are] not compensable by the HMO,” and that it enforces this “gag-order policy” by “reprimand[ing] or even terminating] physicians who disclose that CIGNA will not cover particular forms of treatment that might be useful to the patient.” (Compl. at ¶¶ 69-72; Plaintiffs Memorandum in Opposition to Motion (“PL Mem.”) at 22.) Weiss claims that by implementing this policy, CIGNA has “breached its fiduciary obligations and has breached its implied covenant of good faith and fair dealing.” (Compl. at ¶ 78.)
Weiss’ claim for breach of an implied covenant of good faith and fair dealing is preempted by the terms of ERISA.
See
29 U.S.C. § 1144(a);
Tolle v. Carroll Touch, Inc.,
A person is a fiduciary of a benefit plan for the purposes of ERISA “to the extent (i) he exercises any discretionary authority or discretionary control respecting management of such plan ... or (iii) he has any discretionary authority or discretionary responsibility in the administration of such plan.” 29 U.S.C. § 1002(21)(A). An HMO can be an ERISA fiduciary when it exercises such discretion.
See, e.g., O’Reilly v. Ceuleers,
CIGNA acts in a fiduciary capacity— and therefore comes under the obligations of loyalty imposed by ERISA — to the extent that it exercises discretionary control over the communication of medical information to Plan participants by their physicians. CIGNA’s alleged policy of restricting the disclosure of non-covered treatment options would, if true, directly undermine the ability of plan participants to have unfettered access to all relevant information relating to their physical or mental condition and treatment options. 1 Such a policy would thereby constitute a breach of CIGNA’s duty under ERISA to manage the Plan “solely in the interest of the participants.” It is true that a physician has an independent duty to provide full information to his or her patients, a duty which “is not altered by limitations in the coverage provided by the patient’s managed care plan.” {See Council on Ethical and Judicial Affairs, American Medical Association, Ethi *752 cal Issues in Managed Care, Council Report, 273 JAMA 330 (Jan. 25, 1995)). A patient therefore cannot be deprived of such information absent an ethical breach on the part of the physician. Nonetheless, CIGNA’s alleged rule mandating such an ethical breach upon pain of termination would provide many physicians with no meaningful choice and would effectively limit the amount of information available to Plan participants.
Weiss has offered thin evidence indeed, confined to hearsay submissions, to support her assertion that a “gag order” policy actually exists on the part of CIGNA. Nevertheless, she has cleared the initial hurdle of. Fed.R.Civ.P. 12 and is entitled to proceed with discovery on her claim. Accordingly, defendants’ motion to dismiss is denied with regard to Weiss’ fiduciary duty claim arising from CIGNA’s alleged “gag order” policy.
B. Weiss’ Fiduciary Duty Claim Regarding Physician Compensation
Defendants’ motion to dismiss is GRANTED with regard to plaintiffs fiduciary duty claims arising from CIGNA’s alleged financial arrangements with its participating physicians. (Compl. at ¶ 78.) Weiss contends that CIGNA pays its primary care physicians (“PCPs”) pursuant to a system “designed for only one purpose — to influence its PCPs to reduce the amount of treatment they provide to their patients or the number of referrals they make to specialists.” (PI. Mem at 7.) Specifically, the Complaint alleges that CIGNA doctors are compensated through “capitation” payments and “withholds,” whereby CIGNA pays a small monthly fee per patient regardless of the amount of care actually provided and then withholds a portion of those payments “to be returned only if the doctor has sufficiently low rates of referrals to specialists.” (Id.) It is further alleged that CIGNA pays financial bonuses to PCPs “who keep the referral and hospitalization rates of their patients below the average level of their peers.” (Compl. at ¶ 57.)
Weiss asserts that these methods of payment constitute “a scheme by which [CIG-NA] seeks to pressure its participating physicians to undertreat their patients in order to maximize profits” which creates a “direct conflict of interest in the exercise by the PCPs of their medical judgment,” and “causfes] the breach of fiduciary duty owed by the participating physicians to the plaintiff and the Class Members.” (Compl. at ¶¶ 38, 51, 78.) Accordingly, she claims that CIGNA has violated its fiduciary duties toward Plan participants, see ERISA § 404(a)(1), 29 U.S.C. § 1104(a)(1), and has also breached its implied covenant of good faith and fair dealing. (Compl. at ¶ 78.)
As a threshold matter, as with the alleged “gag order” policy discussed above, Weiss’ claim for breach of the implied covenant of good faith and fair dealing is preempted by ERISA and is dismissed. 29 U.S.C. § 1144(a). Unlike in the case of the alleged “gag order” policy, however, Weiss’ fiduciary duty claim is also dismissed here, on the ground that Weiss has identified no breach of any fiduciary obligation owed by CIGNA to Plan participants under ERISA. Whereas the alleged “gag order” is driven by a threat of termination and involves the potential deprivation of relevant medical information, Weiss makes no claim here that CIGNA actually coerces physicians to breach their fiduciary duties or endangers any specific rights or benefits to which participants are entitled under the terms of the Plan. CIG-NA’s compensation system requires physicians to weigh their economic interests against their ethical obligations to their patients; as such, it presents dangers of abuse. However, to the extent that a doctor takes advantage of financial incentives and withholds necessary care from his or her patients, that doctor’s ethical breach is not attributable to CIGNA. The profit motive created by the HMO does not make such violations “inevitabl[e],” (Compl. at ¶ 66), and indeed plaintiff has pointed to no fiduciary breach by any physician in the case of any putative class member, nor is it alleged beyond the most speculative terms that such a breach would ever occur in the future.
See Maltz v. Aetna Health Plans of New York,
*753
Weiss’ contention that CIGNA’s compensation package facially violates ERISA simply because it deprives her of her right to receive “medical opinions and referrals unsullied by mixed motives,” (Compl. at ¶ 66), is tantamount to a claim that risk-sharing arrangements in managed care are inherently illegal, a position that is refuted by federal and New York law.
See
42 U.S.C. § 300e(e)(2); 42 C.F.R. § 417.103(b); N.Y. Pub. Health Law § 4403(l)(c). Moreover, plaintiffs concern about the soundness of managed care policy is best suited for resolution by branches of government other than the judiciary,
see, e.g., Ambroze v. Aetna Health Plans of New York, Inc.,
No. 95 Civ. 663KDLC),
C. Weiss’ Fiduciary Duty Claim Regarding the Disclosure of Physician Compensation
CIGNA’s motion to dismiss is also GRANTED with regard to Weiss’ claim that CIGNA has violated ERISA by failing to disclose in the Group Service Agreement (“GSA”) the nature of its physician compensation contracts. (Compl. at ¶¶ 42-52, 77.) Weiss contends that such information affects the ability of current Plan participants to “make an intelligent assessment of whether their physicians’ medical recommendations should be questioned,” (PL Mem. at 13), and that CIGNA’s nondisclosure therefore constitutes a violation of ERISA. (Compl. at ¶ 77.) 4 The claim rests on two statutory grounds: first, Weiss asserts that CIGNA has failed to comply with the mandatory “summary plan description” (“SPD”) disclosure requirements set forth in ERISA § 102, 29 U.S.C. § 1022; in the alternative, she contends that CIGNA has violated a disclosure obligation arising from the general ERISA fiduciary duties of loyalty and prudence set forth in ERISA § 404(a)(1), 29 U.S.C. § 1104(a)(1). Neither of these grounds supports Weiss’ claim.
The SPD argument is twice deficient. To begin with, the SPD disclosure obligation “is placed on the person designated by ERISA as the ‘administrator’ of the plan, not on every fiduciary .”
Lee v. Burkhart,
As noted above, Weiss also purports to find an obligation for CIGNA to disclose the nature of its physician compensation arrangements in ERISA’s general fiduciary obligations of loyalty and prudence, ERISA § 404, 29 U.S.C. § 1104. Plaintiffs argument is unavailing. As a starting point, the general language of a statute “will not be held to apply to a matter specifically dealt with in another part of the same enactment,”
Clifford F. MacEvoy Co. v. United States,
To the extent that the duties of an ERISA fiduciary do go beyond the bounds of express statutory requirements,
see Varity,
— U.S. at---,
Plaintiff relies on the decisions in two other Circuits in
Eddy v. Colonial Life Ins. Co. of America,
Moreover, even under dicta contained in
Eddy
and
Bixler
CIGNA would have no duty
*755
to disclose the nature of its compensation agreements with its physicians, because Weiss has not shown that such information affects “circumstances that threaten interests relevant to the relationship” or that it contains “material facts ... which [she] needs to know for [her] protection in dealing with a third person.”
Eddy,
For the foregoing reasons, ERISA imposes no affirmative obligation upon CIGNA to inform Plan participants about its financial arrangements with participating physicians, and plaintiffs fiduciary duty claim arising from CIGNA’s alleged failure to disclose such arrangements is accordingly dismissed.
D. Weiss’ Claim Regarding CIGNA’s Alleged Breach of the Terms of the Plan
Defendants’ motion to dismiss is GRANTED with regard to plaintiffs claim that defendants have breached the express or implied terms of the Plan. 7 That claim rests on two allegations: first, that CIGNA makes medical determinations based on actuarial guidelines rather than on the basis of “generally accepted medical standards,” as required by the Plan; and second, that CIG-NA requires doctors to obtain pre-authorization for “Outpatient Services,” a requirement which is alleged to be absent from the terms of the Plan.
Neither of Weiss’ allegations states a claim on which relief can be granted. The Plan clearly provides that it is CIGNA’s responsibility to determine what treatment options are “Medically Necessary,” (see Group Service Agreement at 6, 25), and there is no express statement in the Plan of the materials which CIGNA must use to make such determinations. Even accepting as true Weiss’ allegation that CIGNA uses what are known as the Milliman & Robertson Guidelines when deciding the length of hospital stays, (PI. Mem. at 24), and that such guidelines are “highly controversial,” (id.), Weiss has not alleged that CIGNA relies on such guidelines to the exclusion of other factors, nor has she alleged that any of CIGNA’s determinations of “Medical Necessity” have actually departed from “generally accepted medical standards,” either in her own case or in the case of any other putative class member. Instead, her claim challenges the appropriateness of any or all such determinations, a speculative allegation untethered to the terms of the Plan.
Similarly, even taking as true Weiss’ contention that CIGNA requires physicians to obtain pre-authorizations for “Outpatient Services,” Weiss has failed to show why such a practice would violate any express or implied terms of the Plan. The GSA does not prohibit pre-authorizations in general and in *756 deed it specifically requires them for many types of services, including certain outpatient services. Plaintiffs reading of the GSA— which would convert the absence of an explicit requirement of pre-authorization into a prohibition of the same — is insufficient to establish any breach of the terms of the Plan. Moreover, Weiss has failed to explain how such an alleged violation, if true, has harmed or ever could harm her or any other putative class member. For all of the foregoing reasons, plaintiffs claim that CIGNA has violated the terms of the Plan is dismissed.
CONCLUSION
For the reasons set forth above, defendants’ motion is GRANTED in PART and DENIED in PART. Accordingly, the complaint is hereby dismissed, with the exception of plaintiffs claim pursuant to ERISA § 404(a)(1), 29 U.S.C. § 1104(a)(1), for breach of fiduciary duty arising from CIG-NA’s alleged “gag order” policy.
Notes
. For that reason, federal legislation prohibiting HMO gag clauses — i.e., the "Patient Right to Know Act,” H.R. 586 and S. 449, 105th Cong. (1997) — was introduced before the House of Representatives on February 5, 1997 and before the Senate on March 17, 1997. The measure is currently pending.
. This result is unchanged even if Weiss’ claim is taken to arise under ERISA's prohibition against aiding or abetting a co-fiduciary's violation, 29 U.S.C. § 1105, since no allegation has been *753 made of any primary fiduciary breach that could have been known or facilitated by CIGNA.
. See Omnibus Budget Reconciliation Act of 1990 §§ 4204(a) and 4731. Pursuant to that Act, the Federal Health Care Financing Administration recently issued regulations limiting the types of bonuses and incentives that can be paid by HMOs to doctors for controlling the costs of services provided to Medicare and Medicaid patients. See 42 C.F.R. § 417.479 (Jan. 1, 1997).
. In her complaint, Weiss originally claimed that CIGNA had breached its fiduciary duty to
prospective
CIGNA participants by failing to disclose (a) its final decision-making authority over medical treatments, and (b) its economic arrangements with its physicians. (Compl. at ¶¶ 50-51, 77.) Such omissions were allegedly made "for the purpose of inducing class members to join CIGNA and to pay the required premiums.”
(Id.
at ¶ 77.) The Plan, however, does reveal CIG-NA’s decision-making role,
(see
Group Service Agreement at 6, 25), and in any event ERISA fiduciary duties do not govern the distribution of marketing materials to potential plan participants.
See, e.g., F.H. Krear & Co. v. Nineteen Named Trustees,
.
Maltz v. Aetna,
relied upon by plaintiff, is not to the contrary. In
Maltz
the Second Circuit found that an insurer did not violate ERISA when it changed over to a capitation payment agreement with its physicians in place of a fce-l'or-service method of compensating them. In so holding, the court relied in part on the fact that the plaintiff had "renewed her contract ... with full knowledge of these significant changes.”
. To the extent that the result here is inconsistent with the decisions of the Eighth Circuit Court of Appeals in
Shea v. Esensten,
. Weiss’ claim is brought pursuant to ERISA § 502(a)(3), which permits a plaintiff to obtain equitable relief for the breach of any fiduciary duty, including the duly to honor the terms of the Plan.
See also
ERISA § 404(a)(1)(D). Notwithstanding Weiss' contention to the contrary, her claim may not be based on ERISA § 502(a)(1)(B), which permits a beneficiary to sue to "recover benefits due,” to "enforce [her] rights,” or to “clarify [her] rights to future benefits” under the terms of the Plan. A claim brought under that section is essentially a contract claim,
see Tolle,
